|Day Low/High||33.17 / 33.76|
|52 Wk Low/High||33.08 / 41.90|
Thank Morgan Stanley analyst Adam Jonas for all he's shown us on the problem with TSLA.
As hard as it is to believe, there are other carmakers in the world outside of Tesla.
Here is the 2019 manufacturing data (in units) for the big car companies: Tesla - 367k General Motors - 10 million Ford - 5.5 million Fiat Chrysler - 2.2 million Nevertheless, the market capitalization of Tesla (at $89 billion) is the largest for an...
Not the greatest of closes (for Apple or the broad market) -- but after such a strong advance we shouldn't be surprised or disappointed: * Market breadth closed at negative 300 issues net decliners. * FANG traded plus or minus from unchanged -- depe...
This is a market that thrives on growth. Tesla has it in spades.
While this name may not appear like it's ready to pump up, I have some good reasons to invest in it.
There's not going to be a systemic shock to the U.S. economy over the holidays, but the data train starts again on January 10th.
As we roll into the holiday, I don't see a need to play this name; but if you own it or are shorting it, here's my advice.
Consensus estimates that show S&P earnings growing at 9.1% on revenue growth of 5.1% fundamentally ignore the changes happening in the U.S. economy.
The stock opens higher each morning like clockwork and it has no resistance.
We turn our attention, not in the least bit eagerly, but fully focused on what comes next.
The impact of the end of the GM strike was all over the industrial production data for November. The production of motor vehicles/parts rebounded by +12.4% month over month after three straight months of declines. This drove the +1.1% month over mon...
Consumer and investor sentiment seem rock solid at the moment.
After the 266,000 payroll number on Friday, here's my analysis and how to prepare for the months ahead.
With a mini-recession in the sector, all eyes are on Friday's jobs numbers, and the big question now is whether this will play out like 2015 to 2016, or worse.
* Six weeks ago I introduced a new column in my Diary * Rate of change -- both absolutely and relative to consensus expectations -- is likely the most important near-term determinant of stock prices * On balance, last week's data-based changes -- fi...
I have been negative ("Peak Autos") regarding the outlook for the auto sector for more than four years -- having been short both Ford and General Motors on numerous occasions. The worst is likely yet to come (both domestically and overseas). From Da...
Danielle DiMartino Booth is more optimistic that depleted inventories will aid manufacturing, but her concerns about the consumer remain: The U.S. industrial recession is set for a reprieve; future inventories from New York and Philadelphia regions ...
There are opportunities across the board, from high-performance sports cars and EVs to RVs and trucks.
* Four weeks ago I introduced a new column in my Diary * Rate of change (absolutely and relative to consensus expectations) is likely the most important near-term determinant of stock prices * On balance, last week's data-based changes (four positiv...
The RMPIA's 3.8% jump even beat the Nasdaq Composite Index's 3.7% October climb.
Stemline Therapeutics and Entercom Communications seem to have stabilized after notable declines late in the summer.
Today's breadth reversed yesterday's weakness - now standing at about 2-1. The composition of the leadership remains the same - selected technology, large cap industrials and bank/financials. Watching and not trading. On the data front: The October ...
The fact that the indices are so buoyant on the job news is an illustration of how much skepticism and fear there is.
Be careful drawing too strong of a conclusion from these numbers.
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
Teaming up these companies will only dilute the value of Jeep brand.